Good news for those who have been using Maxalt and Maxalt-MLT to treat their Migraines. The patents on both Maxalt products have expired, and several manufacturers now have approvals to produce generic rizatriptan benzoate.
At least two companies, Mylan Pharmaceuticals and Par Pharmaceutical, have begun shipping the tablets in both rizatriptan benzoate tablets and rizatriptan benzoate orally disintegrating tablets, which means they should be available in pharmacies soon.
This news may be of additional interest to parents who have children with Migraine as both rizatriptan benzoate tablets and rizatriptan benzoate orally disintegrating tablets have been FDA approved for children and teens ages six to 17 years of age.
The release of generic rizatriptan benzoate brings the total of generic triptans to three. Sumatriptan (Imitrex) and naratriptan (Amerge) are also available.
Related information: Migraine Abortive Maxalt Approved for Children 6-to 17-Years-Old.
Press Release: "Mylan Launches First Generic Maxalt MLT® Tablets." Mylan Pharmaceuticals. Pittsburgh, Pennsylvania. January 2, 2013.
Press Release. "Par Pharmaceutical Begins Shipment of Rizatriptan Benzoate Tablets." Par Pharmaceuticals. Woodcliff Lake, New Jersey. January 2, 2013.
Get the latest Migraine and headache news, informational articles, tips for living well, and more in my free weekly newsletter. To subscribe, CLICK HERE.